Commonwealth Equity Services’s ADMA Biologics ADMA Stock Holding History

Commonwealth Equity Services’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174K	Buy	20,771 +7,067	+52%	+$64.4K	﹤0.01%	4164
2026 Q1	$123K	Sell	13,704 -28,171	-67%	-$445K	﹤0.01%	4100
2025 Q4	$764K	Sell	41,875 -6,934	-14%	-$117K	﹤0.01%	2811
2025 Q3	$716K	Buy	48,809 +2,401	+5%	+$41.2K	﹤0.01%	2874
2025 Q2	$845K	Buy	46,408 +5,720	+14%	+$117K	﹤0.01%	2722
2025 Q1	$807K	Buy	+40,688	New	+$704K	﹤0.01%	2642
2024 Q4	–	Sell	-10,564	Closed	-$211K	–	4088
2024 Q3	$211K	Sell	10,564 -5,146	-33%	-$80K	﹤0.01%	3648
2024 Q2	$176K	Buy	15,710 +2,950	+23%	+$24.7K	﹤0.01%	3677
2024 Q1	$84K	Sell	12,760 -3,600	-22%	-$19.7K	﹤0.01%	3828
2023 Q4	$74K	Hold	16,360	–	–	﹤0.01%	3712
2023 Q3	$59K	Buy	16,360 +6,250	+62%	+$24.1K	﹤0.01%	3640
2023 Q2	$37K	Hold	10,110	–	–	﹤0.01%	3697
2023 Q1	$33	Sell	10,110 -1,792	-15%	-$6.2K	﹤0.01%	3620
2022 Q4	$46K	Buy	11,902 +1,792	+18%	+$5.53K	﹤0.01%	3522
2022 Q3	$24K	Buy	+10,110	New	+$24.3K	﹤0.01%	3556
2022 Q2	–	Sell	-26,010	Closed	-$47K	–	3664
2022 Q1	$47K	Buy	26,010 +3,000	+13%	+$4.68K	﹤0.01%	3583
2021 Q4	$32K	Sell	23,010 -2,000	-8%	-$2.63K	﹤0.01%	3573
2021 Q3	$28K	Sell	25,010 -5,000	-17%	-$7K	﹤0.01%	3532
2021 Q2	$48K	Sell	30,010 -20,344	-40%	-$35.8K	﹤0.01%	3463
2021 Q1	$88K	Buy	+50,354	New	+$115K	﹤0.01%	3285

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Commonwealth Equity Services's ADMA Position: Q2 2026 in Review

Commonwealth Equity Services increased its ADMA Biologics (ADMA) stake by 52% in Q2 2026, buying an estimated $64.4K and bringing the position to 20,771 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #4164.

Commonwealth Equity Services first reported a position in ADMA in Q1 2021 and has held it in 20 quarters since. The position peaked at $845K in Q2 2025. 75 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Commonwealth Equity Services held 20,771 shares of ADMA Biologics worth $174K as of Q2 2026.
Commonwealth Equity Services bought 7,067 ADMA Biologics shares in Q2 2026, an estimated $64.4K.
ADMA Biologics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4164 holding.
Commonwealth Equity Services first reported a position in ADMA Biologics in Q1 2021 and has held it in 20 quarters since.
Commonwealth Equity Services's ADMA Biologics position peaked at $845K in Q2 2025.
75 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.